Page last updated: 2024-10-31

nefopam and Substance Withdrawal Syndrome

nefopam has been researched along with Substance Withdrawal Syndrome in 1 studies

Nefopam: Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)
nefopam : A racemate comprising equal amounts of (R)- and (S)-nefopam. The hydrochloride is a centrally acting non-opiate analgesic commonly used for the treatment of moderate to severe pain.
5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine : A member of the class of benzoxazocines that is 3,4,5,6-tetrahydro-1H-2,5-benzoxazocine substituted by phenyl and methyl groups at positions 1 and 5 respectively.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, KH1
Chen, YJ1
Wei, CF1
Yen, MH1
Hsueh, WC1
Liao, KC1
Lu, CL1

Other Studies

1 other study available for nefopam and Substance Withdrawal Syndrome

ArticleYear
Prolonged withdrawal delirium in concomitant diphenhydramine and nefopam dependence: A case report.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, May-30, Volume: 34, Issue:4

    Topics: Adult; Analgesics, Non-Narcotic; Delirium; Diphenhydramine; Humans; Hypnotics and Sedatives; Male; N

2010